Neurocysticercosis: Current Perspectives on Diagnosis and Management

被引:31
作者
Butala, Caitlin [1 ,2 ]
Brook, T. M. [2 ]
Majekodunmi, Ayodele O. [1 ,2 ]
Welburn, Susan Christina [1 ,2 ]
机构
[1] Zhejiang Univ, Sch Med, Zhejiang Univ Univ Edinburgh Inst, Haining, Peoples R China
[2] Univ Edinburgh, Infect Med, Deanery Biomed Sci, Edinburgh Med Sch,Coll Med & Vet Med, Edinburgh, Midlothian, Scotland
关键词
neurocysticercosis; cysticercosis; epilepsy; mass drug administration; anthelmintics; drug resistance; Taenia solium; taeniasis; TAENIA-SOLIUM CYSTICERCOSIS; LINKED IMMUNOELECTROTRANSFER BLOT; PORCINE CYSTICERCOSIS; ANTHELMINTIC RESISTANCE; PREVALENCE; PIGS; ANTIGENS; CRITERIA; DISEASES; TRANSMISSION;
D O I
10.3389/fvets.2021.615703
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Porcine cysticercosis, human taeniasis, and (neuro)cysticercosis are endemic in many low- and middle-income countries (LMIC) where they present a significant health burden to affected communities. Neurocysticercosis (NCC) is one of the leading causes of human epilepsy in many hyperendemic regions in Latin America, Asia, and sub-Saharan Africa. The World Health Organization (WHO) reports an estimated 2.5-8.3 million cases of NCC annually with a disability-adjusted life year (DALY) burden of 2.8 million, but as for all neglected tropical diseases (NTDs), these values are likely to be underestimated. Diagnosis of NCC is complex and most accurately diagnosed using clinical neuroimaging that is unavailable in most hyperendemic regions in LMIC. On January 28, 2021, WHO will launch its road map for the NTDs' "Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030." Taeniasis/cysticercosis is targeted for control success considered as steady increase in the number of countries with intensified control in hyperendemic areas [increasing from 2 (3%) in 2020 to 4 (6%) in 2023, to 9 (14%) by 2025, and to 17 (27%) by 2030]. Cross-cutting targets that include 100% access to at least basic water supply, sanitation, and hygiene in areas endemic for NTDs and 75% integrated treatment coverage for preventative chemotherapy will additionally impact on the taeniasis/cysticercosis/NCC complex. With no vaccine available for humans, prevention of infection depends on communication to the public of the life cycle of a complex zoonosis to promote behavior change, underpinned by practical control measures including treatment of human taeniasis and (neuro)cysticercosis with albendazole and praziquantel [widely used as part of the mass drug administration (MDA) deworming programs], surgery where appropriate, and effective vaccination and deworming for pigs supported by meat inspection. Here, we review recent advances in tools and implementation for Taenia solium taeniasis/(neuro)cysticercosis (TSTC) control and milestones on the onward path to elimination.
引用
收藏
页数:10
相关论文
共 92 条
[1]  
Adesokan Hezekiah Kehinde, 2019, Pan Afr Med J, V32, P145, DOI 10.11604/pamj.2019.32.145.10695
[2]   Albendazole: a new drug for human parasitoses [J].
Albanese, G ;
Venturi, C .
DERMATOLOGIC CLINICS, 2003, 21 (02) :283-+
[3]  
[Anonymous], 2017, Soil-transmitted helminthiases 2017
[4]  
[Anonymous], 2019, MERCK MANUALS
[5]  
[Anonymous], 2019, HUMAN TNF ALPHA ANTI
[6]  
[Anonymous], 2015, 19th WHO Model List of Essential Medicines (WHO Model List of Essential Medicines
[7]   Antibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis [J].
Arroyo, Gianfranco ;
Rodriguez, Silvia ;
Lescano, Andres G. ;
Alroy, Karen A. ;
Bustos, Javier A. ;
Santivanez, Saul ;
Gonzales, Isidro ;
Saavedra, Herbert ;
Javier Pretell, E. ;
Gonzalez, Armando E. ;
Gilman, Robert H. ;
Tsang, Victor C. W. ;
Garcia, Hector H. .
CLINICAL INFECTIOUS DISEASES, 2018, 66 (02) :282-288
[8]   Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? [J].
Bergquist, Robert ;
Utzinger, Jurg ;
Keiser, Jennifer .
INFECTIOUS DISEASES OF POVERTY, 2017, 6
[9]  
Boudsocq A, 1999, WAAVP 17 INT C COP
[10]   A MONOCLONAL ANTIBODY-BASED ELISA FOR THE DETECTION OF CIRCULATING EXCRETORY SECRETORY ANTIGENS IN TAENIA-SAGINATA CYSTICERCOSIS [J].
BRANDT, JRA ;
GEERTS, S ;
DEDEKEN, R ;
KUMAR, V ;
CEULEMANS, F ;
BRIJS, L ;
FALLA, N .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1992, 22 (04) :471-477